Orthopedic implants face persistent clinical challenges of peri-implant infection and impaired osseointegration, especially in high-risk populations with trauma, osteoporosis, or diabetes. Herein, we report a coating-free strategy integrating three-dimensional (3D) printing and electrochemical anodization to fabricate porous titanium alloy implants with TiO2 nanotube (TNT) micro/nano hybrid surfaces. The TNT layer features tunable nanoscale dimensions. In vitro evaluations demonstrate that TNT surfaces exert diameter-dependent biological effects: small-diameter TNTs favor early human bone marrow mesenchymal stem cell (hBMSC) adhesion and proliferation, whereas large-diameter TNTs exhibit the strong antibacterial activity and potent osteogenic differentiation potential. Additionally, TNTs induce transient early M1 macrophage polarization, which synergizes with intrinsic contact-mediated antibacterial activity to accelerate pathogen clearance. Mechanistic investigations reveal that TNTs inhibit Staphylococcus aureus (S. aureus) adhesion and biofilm formation by downregulating topoisomerase I (TopA) to disrupt bacterial DNA topology homeostasis. For osteogenesis, TNTs modulate Filamentous actin (F-actin) cytoskeleton organization and XB130 adaptor protein expression in hBMSCs, thereby activating the PI3K/Akt/GSK3β/β-catenin signaling pathway to drive osteogenic differentiation. In vivo studies using rabbit femoral condyle models confirm that TNT implants exhibit markedly reduced bacterial burden in an infection model and enhanced bone-implant integration. Collectively, these results indicate that TNT 3D-printed titanium implants offer a synergistic platform combining antibacterial defense and enhanced osteointegration. This work provides a mechanistic understanding and preclinical validation for a clinically translatable surface-engineering strategy for next-generation orthopedic implants.
Background Bacterial infection and insufficient osseointegration of titanium-based implants remain major clinical challenges. Conventional drug-loaded coatings often fail to simultaneously achieve long-term antibacterial activity and the construction of an osteogenic microenvironment. Methods In this study, a graphene oxide-supported silver nanoparticle/silk fibroin (GO@Ag/SF) composite coating was developed and modified via micro-arc oxidation. By precisely controlling the GO/AgNO3 volume ratio, the antibacterial and osteogenic performances of the coatings were systematically evaluated. A rat model of infectious bone defect was employed to verify the in vivo therapeutic efficacy. Results The optimized GO@Ag-2/SF coating exhibited pH-responsive sustained Ag+ release, with cumulative release increasing from 0.23 μg/mL under physiological conditions to 0.69 μg/mL under acidic conditions over 672 h. Under NIR irradiation, the coating reached 59.8°C within 10 min and achieved potent antibacterial activity against S. aureus and E. coli, with inhibition rates up to 98.3 ± 1.2%. The GO@Ag-2/SF coating also promoted osteogenic differentiation by enhancing ALP activity, collagen secretion, calcium mineralization, and the expression of RUNX-2, ALP, COL-I, and OCN. In vivo, GO@Ag-2/SF reduced inflammatory infiltration and improved peri-implant bone regeneration, with increased BIC, BV/TV, and Tb.Th and reduced Tb.Sp. Moreover, pull-out testing demonstrated the highest bone-implant mechanical fixation in the GO@Ag-2/SF group, confirming enhanced functional osseointegration in the infected bone defect model. Conclusion Through the synergistic effects of its components, the GO@Ag/SF coating established a dynamic antibacterial-osteogenic balance, offering a promising strategy for the repair of infectious bone defects.
Wanliang Yang, Jingwei Bi, Xin-Xin Ji et al.· Bioactive Materials· 0 citations